Want to see AU:ZNO full AI Analyst Report?
ZNO Stock Chart & Stats
AU$0.08
<AU$0.01(8.00%)
At close: 4:00 PM EST
AU$0.08
<AU$0.01(8.00%)
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.18
Previous CloseN/A
Volume41.30K
Average Volume (3M)29.84K
Market Cap
AU$22.75M
Enterprise ValueAU$22.01
Total Cash (Recent Filing)AU$220.15K
Total Debt (Recent Filing)AU$298.54K
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Feb 25, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.08%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding406,211,760
10 Day Avg. Volume10,003
30 Day Avg. Volume29,836
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)7.42
Price to Sales (P/S)14.50
P/FCF Ratio-16.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundThe 2026 revenue rebound indicates renewed demand for the company’s antimicrobial and sanitising products. If maintained, stronger sales can improve operating leverage, support broader market reach, and provide a foundation for restoring profitability over the next several quarters.
Gross Margin RecoveryA return to roughly 40% gross margin is a meaningful improvement after deeply negative margins in 2024 and 2025. Better product economics could strengthen the business model, create more capacity to fund operations, and improve the potential for future earnings conversion.
Modest LeverageLow leverage reduces solvency pressure relative with highly indebted businesses and leaves the company less exposed to interest costs and refinancing demands. This balance-sheet characteristic provides some financial flexibility while management works to improve earnings and cash generation.
Bears Say
Persistent UnprofitabilityFive consecutive years of losses show that the recent sales and gross-margin recovery has not yet produced a sustainable earnings model. The deeply negative 2026 net margin limits internally funded growth, increases dependence on available capital, and weakens confidence in near-term profitability.
Ongoing Cash BurnRepeated negative operating and free cash flow demonstrates that reported business activity is not translating into cash resources. Continued cash burn can restrict investment in product and distribution expansion, increase financing needs, and make the company more vulnerable if losses persist.
Capital ErosionNegative returns on equity combined with a material decline in equity indicate that accumulated losses are eroding the company’s capital base. This weakens long-term financial resilience, reduces the buffer available to absorb further losses, and makes a durable recovery more dependent on improved operating performance.
Zoono Group Limited News
ZNO FAQ
What was Zoono Group Limited’s price range in the past 12 months?
Zoono Group Limited lowest share price was AU$0.03 and its highest was AU$0.18 in the past 12 months.
What is Zoono Group Limited’s market cap?
Zoono Group Limited’s market cap is AU$22.75M.
When is Zoono Group Limited’s upcoming earnings report date?
Zoono Group Limited’s upcoming earnings report date is Feb 25, 2027 which is in 158 days.
How were Zoono Group Limited’s earnings last quarter?
Zoono Group Limited released its earnings results on Aug 20, 2026. The company reported -AU$0.001 earnings per share for the quarter.
Is Zoono Group Limited overvalued?
According to Wall Street analysts Zoono Group Limited’s price is currently Overvalued.
Does Zoono Group Limited pay dividends?
Zoono Group Limited pays a Notavailable dividend of AU$0.03 which represents an annual dividend yield of 2.08%. See more information on Zoono Group Limited dividends here
What is Zoono Group Limited’s EPS estimate?
Zoono Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zoono Group Limited have?
Zoono Group Limited has 406,211,760 shares outstanding.
What happened to Zoono Group Limited’s price movement after its last earnings report?
Zoono Group Limited reported an EPS of -AU$0.001 in its last earnings report. Following the earnings report the stock price went down -5.66%.
Which hedge fund is a major shareholder of Zoono Group Limited?
Currently, no hedge funds are holding shares in AU:ZNO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zoono Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
75.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-10.04%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Zoono Group Limited
Zoono Group Limited, along with its associated entities, specializes in the innovation, development, and global distribution of a variety of antimicrobial solutions, catering to both the New Zealand market and international clientele. Their product line features items such as hand cleansers, specialized textile applications, mold remediation treatments, and surface disinfectants. Zoono provides its services to a broad spectrum of industries, including the aviation, medical, early education, facilities management, transportation, academic, and hospitality sectors. The firm was established in 1986 and maintains its principal operations from Auckland, New Zealand.
Technical Analysis
Pental Ltd.
―
Mcpherson'S Limited
―
―
EVE Health Group Limited
―
Skin Elements Limited
―